Form 4: ORTHOPEDIATRICS CEO Sells Shares for Tax
Insider Transaction Report
ORTHOPEDIATRICS CORP's President and CEO, David R. Bailey, sold 19,535 common shares at $17.25 to cover tax obligations from restricted stock vesting.
Summary
- David R. Bailey, President and CEO of ORTHOPEDIATRICS CORP, reported a transaction involving the sale of common stock.
- A total of 19,535 shares of common stock were sold on March 16, 2026.
- The shares were disposed of at a price of $17.25 per share.
- The primary purpose of this sale was to satisfy tax withholding obligations upon the vesting of restricted shares.
- Following this transaction, David R. Bailey beneficially owns 298,020 shares, which includes 187,891 restricted stock awards.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this transaction as neutral. It is a routine, non-discretionary sale to cover tax liabilities associated with equity compensation, rather than a signal of management's confidence or lack thereof in the company's future.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that insider sales to cover tax obligations upon restricted stock vesting are a common and routine occurrence for executives, not typically indicative of a change in sentiment towards the company's future prospects. This transaction is specific to the individual's compensation structure rather than a broader industry trend.
Stakeholder Impact
- Shareholders: Minimal impact as this is a routine, non-discretionary sale for tax purposes, not signaling a change in management's outlook.
Key Dates
| Date | Description |
|---|---|
| 03/16/2026 | Transaction Date for the sale of common stock. |
| 03/17/2026 | Signature Date of the reporting person's attorney-in-fact. |
Recommendation
holdThis Form 4 filing details a routine, non-discretionary sale of shares by the CEO to cover tax obligations upon restricted stock vesting. Such transactions are common and do not typically reflect a change in the executive's confidence in the company's long-term prospects. Therefore, it provides no new fundamental information to alter an existing investment thesis, warranting a 'hold' recommendation.
Keywords
ORTHOPEDIATRICS CORP, KIDS, David R. Bailey, Insider Trading, Form 4, Stock Sale, Tax Withholding, Restricted Stock, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.